Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Treatment
Volume 2015, Article ID 745048, 8 pages
http://dx.doi.org/10.1155/2015/745048
Research Article

Physicians Experience with and Expectations of the Safety and Tolerability of WHO-Step III Opioids for Chronic (Low) Back Pain: Post Hoc Analysis of Data from a German Cross-Sectional Physician Survey

1Institute for Neurological Sciences, Nordostpark 51, 90411 Nuernberg, Germany
2Mundipharma GmbH, Mundipharmastraße 2, 65549 Limburg, Germany
3Interdisciplinary Center for Pain and Palliative Care Medicine, Schillerplatz 8/1, 73033 Goeppingen, Germany

Received 29 July 2015; Accepted 21 September 2015

Academic Editor: Steve McGaraughty

Copyright © 2015 Michael A. Ueberall et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. Braden, M.-Y. Fan, M. J. Edlund, B. C. Martin, A. DeVries, and M. D. Sullivan, “Trends in use of opioids by noncancer pain type 2000–2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP Study,” Journal of Pain, vol. 9, no. 11, pp. 1026–1035, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. B. D. Sites, M. L. Beach, and M. A. Davis, “Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users,” Regional Anesthesia and Pain Medicine, vol. 39, no. 1, pp. 6–12, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. C. S. Zin, L.-C. Chen, and R. D. Knaggs, “Changes in trends and pattern of strong opioid prescribing in primary care,” European Journal of Pain, vol. 18, no. 9, pp. 1343–1351, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Schubert, P. Ihle, and R. Sabatowski, “Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data,” Deutsches Arzteblatt International, vol. 110, no. 4, pp. 45–51, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Jaeschke, “Acetaminophen: dose-dependent drug hepatotoxicity and acute liver failure in patients,” Digestive Diseases, vol. 33, no. 4, pp. 464–471, 2015. View at Publisher · View at Google Scholar
  6. T. Stammschulte, W. D. Ludwig, B. Mühlbauer, E. Bronder, and U. Gundert-Remy, “Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990–2012,” European Journal of Clinical Pharmacology, vol. 71, no. 9, pp. 1129–1138, 2015. View at Publisher · View at Google Scholar
  7. A. Lanas, M. A. Perez-Aisa, F. Feu et al., “A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use,” American Journal of Gastroenterology, vol. 100, no. 8, pp. 1685–1693, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. W. B. White, G. Faich, A. Whelton et al., “Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac,” American Journal of Cardiology, vol. 89, no. 4, pp. 425–430, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. European Medicines Agency, “Diclofenac-containing medicines,” 2015, http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Diclofenac-containing_medicines/human_referral_prac_000009.jsp&mid=WC0b01ac05805c516f.
  10. European Medicines Agency, “Ibuprofen- and dexibuprofen-containing medicines,” July 2015, http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Ibuprofen_and_dexibuprofen_containing_medicines/human_referral_prac_000045.jsp&mid=WC0b01ac05805c516f.
  11. N. Moore, C. Pollack, and P. Butkerait, “Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs,” Therapeutics and Clinical Risk Management, vol. 11, pp. 1061–1075, 2015. View at Google Scholar
  12. R. Chou, G. J. Fanciullo, P. G. Fine et al., “Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain,” Journal of Pain, vol. 10, no. 2, pp. 113–130, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Chou and L. Huffman, Use of Chronic Opioid Therapy in Chronic Noncancer Pain: Evidence Review, American Pain Society, Glenview, Ill, USA, 2009, http://americanpainsociety.org/uploads/education/guidelines/chronic-opioid-therapy-cncp.pdf.
  14. National Opioids Use Guideline Group (NOUGG), Canadian Guidelines for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain, Version 5.6, 2010, http://nationalpaincentre.mcmaster.ca/documents/opioid_guideline_part_b_v5_6.pdf.
  15. The British Pain Society, Opioids for Persistent Pain: Good Practice. A Consensus Statement Prepared on Behalf of the British Pain Society, the Royal College of Anaesthetists, the Royal College of General Practitioners and the Faculty of Addictions of the Royal College of Psychiatrists, The British Pain Society, London, UK, 2010.
  16. W. Häuser, F. Bock, P. Engeser et al., “Recommendations of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain,” Schmerz, vol. 29, no. 1, pp. 109–130, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Sehgal, L. Manchikanti, and H. S. Smith, “Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse,” Pain Physician, vol. 15, no. 3, pp. ES67–ES92, 2012. View at Google Scholar · View at Scopus
  18. A. DuPen, D. Shen, and M. Ersek, “Mechanisms of opioid-induced tolerance and hyperalgesia,” Pain Management Nursing, vol. 8, no. 3, pp. 113–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Lee, S. Silverman, H. Hansen, V. Patel, and L. Manchikanti, “A comprehensive review of opioid-induced hyperalgesia,” Pain Physician, vol. 14, no. 2, pp. 145–161, 2011. View at Google Scholar · View at Scopus
  20. G. H. H. Mueller-Schwefe and M. A. Ueberall, “Stellenwert stark wirksamer Opioide aus Behandlersicht: Ergebnisse einer Querschnittbefragung von 4283 opioidverordnenden Ärzten,” MMW—Fortschritte der Medizin, vol. 156, no. 5, supplement, pp. 98–105, 2014. View at Publisher · View at Google Scholar
  21. J. H. Lee, S.-C. Yun, J.-G. Lee et al., “The impact of fentanyl matrix on pain and function in spinal disorder-related chronic pain: an open label trial in Korea,” Asian Spine Journal, vol. 5, no. 2, pp. 91–99, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Ueberall and G. H. Mueller-Schwefe, “Safety and efficacy of oxycodone/naloxone vs. oxycodone vs. morphine for the treatment of chronic low back pain: results of a 12 week prospective, randomized, open-label blinded endpoint streamlined study with prolonged-release preparations,” Current Medical Research and Opinion, vol. 31, no. 7, pp. 1413–1429, 2015. View at Publisher · View at Google Scholar
  23. R. K. Portenoy and K. M. Foley, “Chronic use of opioid analgesics in non-malignant pain: report of 38 cases,” Pain, vol. 25, no. 2, pp. 171–186, 1986. View at Publisher · View at Google Scholar · View at Scopus
  24. D. A. Fishbain, H. L. Rosomoff, and R. S. Rosomoff, “Drug abuse, dependence and addiction in chronic pain patients,” Clinical Journal of Pain, vol. 8, no. 2, pp. 77–85, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. GBD 2013 Mortality and Causes of Death Collaborators, “Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013,” The Lancet, vol. 385, no. 9963, pp. 117–171, 2014. View at Publisher · View at Google Scholar
  26. Pain & Policy Studies Group of the University of Wisconsin and the WHO Collaborating Center, 2015, http://www.painpolicy.wisc.edu/global.